Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DOVA

Dova Pharmaceuticals (DOVA) Stock Price, News & Analysis

Dova Pharmaceuticals logo

About Dova Pharmaceuticals Stock (NASDAQ:DOVA)

Advanced Chart

Key Stats

Today's Range
$28.04
$28.04
50-Day Range
$28.04
$28.04
52-Week Range
$5.62
$28.54
Volume
35,036 shs
Average Volume
499,313 shs
Market Capitalization
$807.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DOVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dova Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DOVA Stock News Headlines

Lifelines Ahead
Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
Fulcrum swings back up after FDA lifts clinical hold
See More Headlines

DOVA Stock Analysis - Frequently Asked Questions

Dova Pharmaceuticals Inc (NASDAQ:DOVA) issued its earnings results on Tuesday, August, 6th. The company reported ($0.60) earnings per share for the quarter, missing the consensus estimate of ($0.57) by $0.03. The firm earned $3.52 million during the quarter, compared to analysts' expectations of $5.63 million. Dova Pharmaceuticals had a negative trailing twelve-month return on equity of 101.60% and a negative net margin of 544.09%.

Dova Pharmaceuticals (DOVA) raised $66 million in an initial public offering (IPO) on Thursday, June 29th 2017. The company issued 4,100,000 shares at $15.00-$17.00 per share. J.P. Morgan, Jefferies and Leerink Partners acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dova Pharmaceuticals investors own include Global Blood Therapeutics (GBT), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Fate Therapeutics (FATE), Fibrocell Science (FCSC), Tesaro (TSRO) and Viking Therapeutics (VKTX).

Company Calendar

Last Earnings
8/06/2019
Today
9/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DOVA
CIK
1685071
Fax
N/A
Employees
115
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$72.28 million
Net Margins
-544.09%
Pretax Margin
N/A
Return on Equity
-101.60%
Return on Assets
-67.21%

Debt

Debt-to-Equity Ratio
0.41
Current Ratio
5.64
Quick Ratio
5.37

Sales & Book Value

Annual Sales
$10.35 million
Price / Sales
78.02
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.71 per share
Price / Book
10.35

Miscellaneous

Outstanding Shares
28,800,000
Free Float
N/A
Market Cap
$807.55 million
Optionable
Optionable
Beta
2.74
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:DOVA) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners